SpacePharma
PrivateLast Round
Accelerator
Dec 4, 2024
Est. Valuation
$100M
Total Funding Raised
$24.76M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
SpacePharma operates in Healthcare & Life Sciences and is based in Courgenay. Its latest recorded funding round was an Accelerator round in December 2024.
SpacePharma is a biotechnology company that provides miniaturized, remotely controlled laboratories for conducting research and development in the microgravity of space.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Space Technology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpacePharma Comparables
Compare SpacePharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Space LiinTech | 85% | |
| Yuri | 83% | |
| Space Tango | 83% |
For institutional investors. Book with your work email.
SpacePharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 4, 2024 | ||||
| VC Round | Dec 1, 2024 | ||||
| Series B | Feb 12, 2021 | ||||
| Series A | Feb 1, 2021 | ||||
| Grant | Nov 6, 2019 | ||||
Grant | Jun 13, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SpacePharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | VC Round, Accelerator |
| Israel Innovation Authority | Grant |
| State of Mind Ventures | Seed |
| Space Florida | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 96% MoM.
- May 20, 2026
Monthly visitors grew 266% MoM, reaching 3.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 18, 2026
SpacePharma Inc. launches DIDO-2, an ISISPACE-built CubeSat that validates a miniaturized end-to-end pharmaceutical laboratory in orbit, aboard an Indian PSLV rocket on Feb 15th '17 alongside more than 100 other satellites.
For institutional investors. Book with your work email.
SpacePharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SpacePharma's valuation, stock price, and market status.
Is SpacePharma a public or private company?
SpacePharma is a private company.
What is the current stock price of SpacePharma?
SpacePharma is a private company, so its shares have no public market price. Caplight tracks SpacePharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SpacePharma worth (valuation)?
SpacePharma's valuation is estimated at $100.0M based on funding round data.
Can I buy SpacePharma stock?
SpacePharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SpacePharma's last funding round?
SpacePharma's most recent funding round was Accelerator on December 4, 2024.
Who are the main investors in SpacePharma?
Key investors in SpacePharma include European Innovation Council Fund, Israel Innovation Authority, State of Mind Ventures, Space Florida.
Will SpacePharma IPO soon?
No public IPO plans have been announced for SpacePharma.
How can I track SpacePharma secondary market activity?
Caplight tracks bids, offers, and trades in SpacePharma's shares on secondary markets.